[1] FRANCISCO E C, JUNIORJ N, TELLES F Q, et al.Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres[J].Clin Microbiol Infect,2019,25(7):909.e1-909.e5. [2] 张德全,夏志宽,吕雪莲,等. 阿萨希毛孢子菌感染致病机制的研究进展[J]. 临床皮肤科杂志, 2015, 44(12):841-843. [3] 黄越燕,王露露,季慧.植物多糖纯化分离方法研究进展[J].中华中医药学刊,2016,34(3):671-674. [4] 宗克强,罗树权,谭小梅.肺炎链球菌荚膜多糖纯化及质量控制方法的研究现状[J].微生物学免疫学进展,2021,49(3):82-87. [5] 赖锐,宋英,刘惟优,等.隐球菌荚膜多糖GXM纯化方法的改良研究[J].中国真菌学杂志,2019,14(4):228-231. [6] ZIMBRES A C G, ALBUQUERQUE P C, JOFFE L S, et al. A glucuronoxylomannan-like glycan produced by Trichosporon mucoides[J]. Fungal Genet Biol, 2018,121:46-55. DOI:10.1016/j.fgb.2018.09.009. [7] CHERNIAK R, MORRIS L C, ANDERSON B C, et al. Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans[J]. Infect Immun, 1991, 59(1):59-64. [8] 李平,谭宏月,胡婵,等.新生隐球菌GXM的纯化及其对巨噬细胞甘露糖受体表达调节的研究[J].中国真菌学杂志,2012,7(5):265-268. [9] ZHANG J X, CHEN M, WEN C T, et al. Structural characterization and immunostimulatory activity of a novel polysaccharide isolated with subcritical water from Sagittaria sagittifolia L[J]. Int J Biol Macromol,2019,133:11-20. DOI:10.1016/j.ijbiomac.2019.04.077. [10] 阴新负,彭效明,李翠清,等.桑叶生物碱和多糖的分离纯化研究进展[J].中医药导报,2016,22(14):108-110,113. [11] FONSECA F L, FRASES S, CASADEVALL A, et al. Structural and functional properties of the Trichosporon asahii glucuronoxylomannan[J]. Fungal Genet Biol, 2009, 46(6-7):496-505. [12] 贾鑫淼, 肖盟, 孙天舒,等. 格特隐球菌基因组学研究进展[J]. 协和医学杂志,2019,10(5):505-513. |